90 related articles for article (PubMed ID: 27450787)
1. Binding characterization, synthesis and biological evaluation of RXRα antagonists targeting the coactivator binding site.
Xu D; Guo S; Chen Z; Bao Y; Huang F; Xu D; Zhang X; Zeng Z; Zhou H; Zhang X; Su Y
Bioorg Med Chem Lett; 2016 Aug; 26(16):3846-9. PubMed ID: 27450787
[TBL] [Abstract][Full Text] [Related]
2. Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.
Zeng Z; Sun Z; Huang M; Zhang W; Liu J; Chen L; Chen F; Zhou Y; Lin J; Huang F; Xu L; Zhuang Z; Guo S; Alitongbieke G; Xie G; Xu Y; Lin B; Cao X; Su Y; Zhang XK; Zhou H
Cancer Res; 2015 May; 75(10):2049-60. PubMed ID: 25795708
[TBL] [Abstract][Full Text] [Related]
3. NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell.
Chen F; Chen J; Lin J; Cheltsov AV; Xu L; Chen Y; Zeng Z; Chen L; Huang M; Hu M; Ye X; Zhou Y; Wang G; Su Y; Zhang L; Zhou F; Zhang XK; Zhou H
Protein Cell; 2015 Sep; 6(9):654-666. PubMed ID: 26156677
[TBL] [Abstract][Full Text] [Related]
4. The effect of antagonists on the conformational exchange of the retinoid X receptor alpha ligand-binding domain.
Lu J; Dawson MI; Hu QY; Xia Z; Dambacher JD; Ye M; Zhang XK; Li E
Magn Reson Chem; 2009 Dec; 47(12):1071-80. PubMed ID: 19757405
[TBL] [Abstract][Full Text] [Related]
5. Targeting truncated RXRα for cancer therapy.
Zhang X; Zhou H; Su Y
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):49-59. PubMed ID: 26494413
[TBL] [Abstract][Full Text] [Related]
6. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260.
Zimmerman TL; Thevananther S; Ghose R; Burns AR; Karpen SJ
J Biol Chem; 2006 Jun; 281(22):15434-40. PubMed ID: 16551633
[TBL] [Abstract][Full Text] [Related]
7. Analysis of ligand binding and protein dynamics of human retinoid X receptor alpha ligand-binding domain by nuclear magnetic resonance.
Lu J; Cistola DP; Li E
Biochemistry; 2006 Feb; 45(6):1629-39. PubMed ID: 16460010
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of allosteric communication in the human PPARalpha-RXRalpha heterodimer.
Venäläinen T; Molnár F; Oostenbrink C; Carlberg C; Peräkylä M
Proteins; 2010 Mar; 78(4):873-87. PubMed ID: 19847917
[TBL] [Abstract][Full Text] [Related]
9. Heme-binding to the nuclear receptor retinoid X receptor alpha (RXRalpha) leads to the inhibition of the transcriptional activity.
Gotoh S; Ohgari Y; Nakamura T; Osumi T; Taketani S
Gene; 2008 Nov; 423(2):207-14. PubMed ID: 18675890
[TBL] [Abstract][Full Text] [Related]
10. RXRalpha acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-dependent manner in gastric cancer cells.
Lin XF; Zhao BX; Chen HZ; Ye XF; Yang CY; Zhou HY; Zhang MQ; Lin SC; Wu Q
J Cell Sci; 2004 Nov; 117(Pt 23):5609-21. PubMed ID: 15494375
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites.
Zhang XK; Su Y; Chen L; Chen F; Liu J; Zhou H
Acta Pharmacol Sin; 2015 Jan; 36(1):102-12. PubMed ID: 25434990
[TBL] [Abstract][Full Text] [Related]
12. Discovery of atorvastatin as a tetramer stabilizer of nuclear receptor RXRα through structure-based virtual screening.
Wang X; Chong S; Lin H; Yan Z; Huang F; Zeng Z; Zhang X; Su Y
Bioorg Chem; 2019 Apr; 85():413-419. PubMed ID: 30665035
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
14. Structure-Activity Relationship Study Enables the Discovery of a Novel
Xu B; Jiang X; Xiong J; Lan J; Tian Y; Zhong L; Wang X; Xu N; Cao H; Zhang W; Zhang H; Hong X; Zhan YY; Zhang Y; Hu T
J Med Chem; 2020 Jun; 63(11):5841-5855. PubMed ID: 32391701
[TBL] [Abstract][Full Text] [Related]
15. Mutation of two residues converts the ligand-binding domain of RXRα into a uniform monomer without impairing the binding of retinoic acid and cofactors.
Wang R; Yue X; Zhu J; Hu R; Li Y; Yang Y; Liu M
Biochem Biophys Res Commun; 2023 Jan; 642():50-56. PubMed ID: 36563628
[TBL] [Abstract][Full Text] [Related]
16. A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer.
Xu RX; Lambert MH; Wisely BB; Warren EN; Weinert EE; Waitt GM; Williams JD; Collins JL; Moore LB; Willson TM; Moore JT
Mol Cell; 2004 Dec; 16(6):919-28. PubMed ID: 15610735
[TBL] [Abstract][Full Text] [Related]
17. CAR2 displays unique ligand binding and RXRalpha heterodimerization characteristics.
Auerbach SS; Dekeyser JG; Stoner MA; Omiecinski CJ
Drug Metab Dispos; 2007 Mar; 35(3):428-39. PubMed ID: 17194715
[TBL] [Abstract][Full Text] [Related]
18. Activation of RAS/ERK alone is insufficient to inhibit RXRα function and deplete retinoic acid in hepatocytes.
Wang AG; Song YN; Chen J; Li HL; Dong JY; Cui HP; Yao L; Li XF; Gao WT; Qiu ZW; Wang FJ; Wang JY
Biochem Biophys Res Commun; 2014 Sep; 452(3):801-7. PubMed ID: 25218146
[TBL] [Abstract][Full Text] [Related]
19. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting.
Cao X; Liu W; Lin F; Li H; Kolluri SK; Lin B; Han YH; Dawson MI; Zhang XK
Mol Cell Biol; 2004 Nov; 24(22):9705-25. PubMed ID: 15509776
[TBL] [Abstract][Full Text] [Related]
20. The eccentric cleavage product of β-carotene, β-apo-13-carotenone, functions as an antagonist of RXRα.
Eroglu A; Hruszkewycz DP; Curley RW; Harrison EH
Arch Biochem Biophys; 2010 Dec; 504(1):11-6. PubMed ID: 20678466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
